Case 33-2005: A 43-year-old man with lower gastrointestinal bleeding

New England Journal of Medicine

Volumn 353, Issue 17, 2005, Pages

  Korzenik, Joshua ^a,b   Chung, Daniel C ^a,b   Digumarthy, Subba ^a,b   Badizadegan, Kamran ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; DNA BINDING PROTEIN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; ANATOMY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; IRON THERAPY; LAPAROTOMY; MALE; MEDICAL EXAMINATION; PATHOLOGY; PRIORITY JOURNAL; RADIOLOGY; SIGMOIDOSCOPY; SMALL INTESTINE OBSTRUCTION; ARTERIOVENOUS MALFORMATION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; EPISTAXIS; GASTROINTESTINAL POLYPOSIS; GENETICS; INTESTINE TUMOR; LIVER DISEASE; LUNG DISEASE; MUTATION; RADIOGRAPHY; RENDU OSLER WEBER DISEASE;

ADULT; ARTERIOVENOUS MALFORMATIONS; DNA-BINDING PROTEINS; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; GERM-LINE MUTATION; HUMANS; INTESTINAL NEOPLASMS; INTESTINAL POLYPOSIS; LIVER DISEASES; LUNG DISEASES; MALE; SMAD4 PROTEIN; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TRANS-ACTIVATORS;

EID: 27244440755     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc059028     Document Type: Article

References (26)

1. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
2. McAllister KA, Baldwin MA, Thukkani AK, et al. Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 1995;4:1983-5.
3. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95.
4. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256-7.
5. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7.
6. Kjeldsen AD, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2000;95:415-8.
7. Rozen P, Samuel Z, Brazowski E. A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol 2003;98:2317-20.
8. McColl I, Bussey HJ, Veale AM, Morson BC. Juvenile polyposis coli. Proc R Soc Med 1964;57:896-7.
9. Nugent KP, Talbot IC, Hodgson SV, Phillips RK. Solitary juvenile polyps: not a marker for subsequent malignancy. Gastroenterology 1993;105:698-700.
10. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis - a precancerous condition. Histopathology 1988;13:619-30.
11. Grotsky HW, Rickert RR, Smith WD, Newsome JF. Familial juvenile polyposis coli: a clinical and pathologic study of a large kindred. Gastroenterology 1982;82:494-501.
12. Coburn MC, Pricolo VE, DeLuca FG, Bland KI. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995;2:386-91.
13. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1998;5:751-6.
14. Scott-Conner CE, Hausmann M, Hall TJ, Skelton DS, Anglin BL, Subramony C. Familial juvenile polyposis: patterns of recurrence and implications for surgical management. J Am Coll Surg 1995;181:407-13.
15. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
16. Xu X, Brodie SG, Yang X, et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 2000;19:1868-74.
17. Howe JR, Bair JL, Sayed MG, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001;28:184-7.
18. Howe JR, Sayed MG, Ahmed AF, et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 2004;41:484-91.
19. Sayed MG, Ahmed AF, Ringold JR, et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 2002;9:901-6.
20. Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004;363:852-9.
21. Gilinsky NH, Elliot MS, Price SK, Wright JP. The nutritional consequences and neoplastic potential of juvenile polyposis coli. Dis Colon Rectum 1986;29:417-20.
22. Ramaswamy G, Elhosseiny AA, Tchertkoff V. Juvenile polyposis of the colon with atypical adenomatous changes and carcinoma in situ: report of a case and review of the literature. Dis Colon Rectum 1984;27:393-8.
23. Jarvinen H, Franssila KO. Familial juvenile polyposis coli: increased risk of colorectal cancer. Gut 1984;25:792-800.
24. Woodford-Richens KL, Rowan AJ, Poulsom R, et al. Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers. Am J Pathol 2001;159:1293-300.
25. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996;7:787-804.
26. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931-6.